Corcept Therapeutics CORT Balance Sheet Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $121.75M-5.4% | $128.67M-5.1% | $135.55M+104% | $66.33M-14.5% | ||
| $251.66M-1.6% | $255.67M+9.9% | $232.67M-36.3% | $365.34M+150% | ||
| $59.79M+10.8% | $53.98M+31.3% | $41.12M+32.4% | $31.06M+12.4% | ||
| $11.09M+210% | $3.58M-56.5% | $8.24M-24.6% | $10.93M-15.7% | ||
| $485.46M+2.9% | $471.6M+2.8% | $458.64M-8.1% | $499.25M+87.4% | ||
| $1.89M-29.7% | $2.69M+1,279% | $195K-69.2% | $633K-36.8% | ||
| $836.65M-0.5% | $840.55M+35.2% | $621.52M+6.5% | $583.43M+37.7% | ||
| $40.44M+163% | $15.38M-11.6% | $17.4M+45.3% | $11.98M+73.4% | ||
| $166.09M+18.0% | $140.77M+34.7% | $104.51M+44.2% | $72.49M+52.5% | ||
| $188.85M+17.3% | $160.96M+40.2% | $114.81M+40.7% | $81.59M+70.2% | ||
| $140K+2.9% | $136K+2.3% | $133K+1.5% | $131K+3.1% | ||
| $643.39M+18.3% | $543.74M+35.1% | $402.53M+35.8% | $296.39M+52.0% | ||
| $647.81M-4.7% | $679.59M+34.1% | $506.71M+1.0% | $501.84M+33.5% | ||
| $836.65M-0.5% | $840.55M+35.2% | $621.52M+6.5% | $583.43M+37.7% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Corcept Therapeutics's total assets?
- Corcept Therapeutics (CORT) holds $814.9M in total assets, down 3.7% year over year.
- How much debt does Corcept Therapeutics have?
- Corcept Therapeutics carries $9.6M in total debt against $638.0M of shareholders' equity, a debt-to-equity ratio of 0.02.
- How much cash does Corcept Therapeutics have?
- Corcept Therapeutics holds $110.0M in cash and equivalents.
- Can Corcept Therapeutics cover its short-term obligations?
- Its current ratio is 2.86 — current assets exceed current liabilities.
- Where does Corcept Therapeutics's balance sheet data come from?
- Every line is extracted from Corcept Therapeutics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
